Stock PHAT PHATHOM PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Phathom Pharmaceuticals, Inc.

Equities

PHAT

US71722W1071

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
9.525 USD -5.60% Intraday chart for Phathom Pharmaceuticals, Inc. -5.13% +4.33%
May. 09 Transcript : Phathom Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024
May. 09 Phathom Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Phathom Pharmaceuticals : First Quarter 2024 Earnings Call – May 2024
PU
Transcript : Phathom Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024
Phathom Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
GL
Stifel Starts Phathom Pharmaceuticals With Buy Rating, $24 Price Target
MT
Phathom Pharmaceuticals to Report First Quarter 2024 Financial Results and Provide Business Update on Thursday, May 9, 2024
GL
Phathom Pharmaceuticals : Corporate Overview – April 2024
PU
Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
GL
Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
AQ
Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, 'VOQUEZNA Can Kick Some Acid'
AQ
Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”
GL
Transcript : Phathom Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 07, 2024
Phathom Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GL
Phathom Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 7, 2024
GL
Phathom Pharmaceuticals Announces VOQUEZNA Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients
AQ
Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients
GL
Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients
AQ
Phathom Pharmaceuticals Announces Voquezna® Tablets for Erosive Gerd and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PHAT Stock
  4. News Phathom Pharmaceuticals, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW